The Fidelity High Dividend ETF (FDVV) offers investors diversified exposure to high-quality dividend-paying companies, with a strong emphasis on technology and AI leaders. While its starting yield of 2.8% is lower than some peers, FDVV's impressive 11.29% five-year dividend growth rate supports strong long-term yield potential. The ETF's tech-heavy allocation drives both growth and risk, performing well during market rallies but potentially underperforming if tech sentiment weakens. The analyst maintains a Buy rating, highlighting FDVV's unique blend of dividend growth and tech exposure as attractive for investors seeking balanced, long-term income.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
